MedTrace Logo

Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention

NCT04236596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2024-08-20

Study results available
· View outcomes & findings →

Summary

This study is to map the pudendal nerve. In this study the researchers will examine subjects who are already receiving an implanted stimulator at their pudendal nerve as part of their normal clinical care.

Conditions

  • Urinary Retention
  • Underactive Bladder

Interventions

DEVICE

Participants received a Neurostimulator, which was used to map the pudendal nerve

Participants in study received neurostimulator at their pudendal nerve as part of their normal clinical care. This neurostimulator was used to map the nerve.

Sponsors & Collaborators

Principal Investigators

  • Tim Bruns, Ph.D. · University of Michigan

  • Priyanka Gupta, M.D. · University of Michigan

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-14
Primary Completion
2023-06-08
Completion
2023-06-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04236596 on ClinicalTrials.gov